Dahu Health Industry Co., Ltd. (SHA:600257)
China · Delayed Price · Currency is CNY 7.16
+0.03 (0.42%)
Feb 13, 2026, 3:00 PM CST
Dahu Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 911.12 | 1,031 | 1,180 | 1,085 | 1,285 | 930.14 |
Other Revenue | 13.35 | 13.35 | 13.18 | 9.47 | 7.79 | 6.37 |
| 924.47 | 1,044 | 1,193 | 1,095 | 1,292 | 936.52 | |
Revenue Growth (YoY) | -14.83% | -12.48% | 9.02% | -15.29% | 37.99% | -15.82% |
Cost of Revenue | 699.6 | 808.85 | 908.8 | 840.03 | 988.81 | 724.01 |
Gross Profit | 224.87 | 235.65 | 284.66 | 254.68 | 303.5 | 212.51 |
Selling, General & Admin | 141.83 | 162.84 | 188.65 | 190.58 | 240.83 | 192.24 |
Research & Development | 0.75 | 0.59 | 0.96 | 0.95 | 0.36 | 6.28 |
Other Operating Expenses | 21.5 | 22.59 | 29.75 | 27.74 | 23.75 | 12.19 |
Operating Expenses | 161.52 | 192.43 | 225.64 | 237.28 | 267.36 | 216.76 |
Operating Income | 63.36 | 43.22 | 59.02 | 17.41 | 36.14 | -4.25 |
Interest Expense | -34.59 | -36.9 | -41.62 | -43.81 | -42.05 | -14.16 |
Interest & Investment Income | 1.62 | 1.54 | 1.66 | 3.22 | 7.33 | 21.13 |
Other Non Operating Income (Expenses) | -3.92 | -5.19 | -1.88 | -2.76 | -3.51 | 2.65 |
EBT Excluding Unusual Items | 26.46 | 2.67 | 17.17 | -25.94 | -2.09 | 5.37 |
Impairment of Goodwill | -19.78 | -19.78 | - | -33.9 | - | - |
Gain (Loss) on Sale of Investments | -3.66 | -3.72 | -2.65 | -6.97 | 0.88 | -0.16 |
Gain (Loss) on Sale of Assets | 1.44 | 1.39 | 5.91 | -0.75 | 2.41 | 0.17 |
Asset Writedown | -6.38 | -6.99 | -4.12 | -2.21 | -192.38 | -10.33 |
Legal Settlements | -0.23 | -0.23 | - | - | - | - |
Other Unusual Items | 2.98 | 3.47 | 11.66 | 11.57 | 8.79 | 34.02 |
Pretax Income | 0.83 | -23.19 | 27.98 | -58.21 | -182.38 | 29.07 |
Income Tax Expense | 37.4 | 37.7 | 15.78 | 15.88 | 15.16 | 8.12 |
Earnings From Continuing Operations | -36.57 | -60.89 | 12.2 | -74.09 | -197.54 | 20.95 |
Minority Interest in Earnings | -19.52 | -16.06 | -20.36 | 2.6 | 17.42 | -16.78 |
Net Income | -56.09 | -76.95 | -8.16 | -71.5 | -180.12 | 4.17 |
Net Income to Common | -56.09 | -76.95 | -8.16 | -71.5 | -180.12 | 4.17 |
Shares Outstanding (Basic) | 473 | 481 | 408 | 477 | 487 | 479 |
Shares Outstanding (Diluted) | 473 | 481 | 408 | 477 | 487 | 479 |
Shares Change (YoY) | 15.51% | 17.90% | -14.41% | -2.09% | 1.53% | -0.37% |
EPS (Basic) | -0.12 | -0.16 | -0.02 | -0.15 | -0.37 | 0.01 |
EPS (Diluted) | -0.12 | -0.16 | -0.02 | -0.15 | -0.37 | 0.01 |
Free Cash Flow | 180.48 | 46.12 | 142.89 | 36.05 | 16.73 | -47.5 |
Free Cash Flow Per Share | 0.38 | 0.10 | 0.35 | 0.08 | 0.03 | -0.10 |
Gross Margin | 24.32% | 22.56% | 23.85% | 23.27% | 23.48% | 22.69% |
Operating Margin | 6.85% | 4.14% | 4.95% | 1.59% | 2.80% | -0.45% |
Profit Margin | -6.07% | -7.37% | -0.68% | -6.53% | -13.94% | 0.45% |
Free Cash Flow Margin | 19.52% | 4.42% | 11.97% | 3.29% | 1.29% | -5.07% |
EBITDA | 81.72 | 64.05 | 83.11 | 42.19 | 65.49 | 21.27 |
EBITDA Margin | 8.84% | 6.13% | 6.96% | 3.85% | 5.07% | 2.27% |
D&A For EBITDA | 18.37 | 20.82 | 24.09 | 24.78 | 29.35 | 25.53 |
EBIT | 63.36 | 43.22 | 59.02 | 17.41 | 36.14 | -4.25 |
EBIT Margin | 6.85% | 4.14% | 4.95% | 1.59% | 2.80% | -0.45% |
Effective Tax Rate | 4481.30% | - | 56.41% | - | - | 27.94% |
Revenue as Reported | 924.47 | 1,044 | 1,193 | 1,095 | 1,292 | 936.52 |
Advertising Expenses | - | 3 | 1.55 | 2.48 | 6.02 | 6.2 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.